Healthcare professionals

Diagnosing venous thromboembolism (VTE) can be challenging, especially in patients admitted for another medical condition such as cancer, kidney failure or even pregnancy.

A great number of patients every year experience thrombosis. Thankfully, once detected, VTE is treatable. 

LEO Pharma has been developing heparin-based products to combat VTE since the 1940s. Harnessing all our knowledge and experience, we are committed to helping healthcare professionals identify and treat high-risk patient groups for VTE – and to prevent needless 
suffering and loss of life.
Treating thrombosis
The challenge for healthcare professionals lies in the characteristics of the patients that are commonly diagnosed with VTE- especially cancer patients. Many of them have co-morbidities, use concomitant medications and, as a result, may present with a burdened physiological profile.
Despite these challenges, heparin-based products continue to be an essential part of thrombosis prophylaxis as well as treatment. 
At LEO Pharma, we have more than 70 years of experience helping healthcare professionals meet their daily clinical challenges in managing thrombosis.


We use cookies on this website

The cookies help us gain a better understanding of how you use our website; display applications and functionalities, to optimise your website experience, to assign a unique identification number to you, and to help you remember your user ID and password when you return to the website. We also use cookies to generate statistical information.

By continuing to browse our website, you are agreeing to our use of cookies

If you want to know more about our cookie policy and how to avoid and delete cookies click here.